gut.bmj1d
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj1d
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome
Visceral hypersensitivity has been recognised as a characteristic of patients with irritable bowel syndrome (IBS). It may be involved in the pathogenesis of abdominal pain/discomfort, and seems to ...
gut.bmj1d
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
aDepartment of Gastrointestinal Medicine, Royal Adelaide Hospital, Adelaide, Australia, bSödra Hõlsocentralen, Hudiksvall, Sweden, cUniversity of Michigan Health ...
gut.bmj1d
Anthranoid laxative abuse--a risk for colorectal cancer?
Anthranoid-containing laxatives--aloe, cascara, frangula, and rheum--may play a role in colorectal cancer. This risk is particularly important in view of the wide abuse of self administered laxatives ...
gut.bmj1d
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Correspondence to Dr Thomas Berg, Section of Hepatology, Department of Internal Medicine, University Hospital Leipzig, Leipzig 04103, Germany; thomas.berg{at}medizin.uni-leipzig.de Objective ...
gut.bmj2d
IDDF2021-ABS-0200 Bacillus amyloliquefaciens combined with resistant starch to ameliorate intestinal inflammation
Background Bacillus amyloliquefaciens (BA) decomposes starch by producing alpha-amylase to produce short-chain fatty acids (SCFA). Resistant starch (RS) can be fermented by colonic microbiota and ...
gut.bmj2d
Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology
Correspondence to Dr Jonathan Hoare, Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK; j.hoare{at}ic.ac.uk This is the first UK national guideline to concentrate on ...
gut.bmj2d
P59 Two-year outcomes of using a stepwise thrombolysis protocol for the management of acute non-malignant portomesenteric thrombosis
Introduction Acute extensive non-malignant non-cirrhotic portomesenteric thrombosis can lead to bowel infarction and frequently does not resolve with anticoagulation. In 2019 we published our first ...
gut.bmj3d
Reducing the incidence of peptic ulcers with ibuprofen-famotidine combined pill, HZT-501 (reduce): phase-III, double-blind multi-centre trials
Introduction The prevention of peptic ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) is hampered by the high pill burden and suboptimal adherence to protective therapy. We therefore ...
gut.bmj3d
Value of genetic testing in the management of pancreatitis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj3d
Fatty acid bile acid conjugates (FABACs)—New molecules for the prevention of cholesterol crystallisation in bile
BACKGROUND Cholesterol gall stones are a frequent disease for which at present surgery is the usual therapy. Despite the importance of bile acids it has become evident that phospholipids are the main ...
gut.bmj3d
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
Objective Extracellular matrix protein 1 (ECM1) serves as a gatekeeper of hepatic fibrosis by maintaining transforming growth ...